Updates are available Correction dated 2024-06-27
Click to view Correction: https://doi.org/10.1186/s40478-024-01788-x
-
Authors
Regal, Joshua A. https://orcid.org/0000-0001-5142-0978
Guerra García, María E.
Jain, Vaibhav
Chandramohan, Vidyalakshmi
Ashley, David M.
Gregory, Simon G.
Thompson, Eric M.
López, Giselle Y.
Reitman, Zachary J.
-
Funding
Funding for this research was provided by:
Pediatric Brain Tumor Foundation
St. Baldrick's Foundation
Emily Beazley’s Kures for Kids Fund
ChadTough Defeat DIPG
funds from the Botha family
developmental funds of the Duke Cancer Institute (P30CA014236)
National Cancer Institute (K08CA2560450)
National Cancer Center for Advancing Translational Sciences of the National Institutes of Health (1KL2TR002554)
Doris Duke Charitable Foundation
- License Information
-
More Information
Article History
Received: 18 December 2022
Accepted: 6 March 2023
First Online: 25 March 2023
Change Date: 27 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40478-024-01788-x
Declarations
:
: Ganglioglioma tumor samples for deep transcriptomics were obtained per Duke University Health System Institutional Review Board (IRB) protocol Pro00072150. The methods were carried out in accordance with the approved guidelines, with written informed consent obtained from all subjects or their guardians where appropriate.
: Not applicable.
: ZJR receives royalties for patents managed by Duke Office of Licensing and Ventures that have been licensed to Genetron Health, and honoraria for lectures to Eisai Pharmaceuticals and Oakstone Publishing Group. EMT is a scientific advisor for Oncohereos Biosciences.
